Upgrade to SI Premium - Free Trial

Form SCHEDULE 13D/A SkinHealth Systems Inc. Filed by: Miller Brian Christopher

May 11, 2026 7:30 PM





If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




schemaVersion:


SCHEDULE 13D




Comment for Type of Reporting Person:
Calculated based on 129,600,040 shares of Class A Common Stock, par value $0.0001 per share ("Class A Shares"), outstanding as of May 5, 2026, as reported on the Issuer's Form 10-Q, filed with the Securities and Exchange Commission ("SEC") on May 7, 2026 (the "Form 10-Q").


SCHEDULE 13D




Comment for Type of Reporting Person:
Calculated based on 129,600,040 shares of Class A Shares outstanding as of May 5, 2026, as reported on the Issuer's Form 10-Q.


SCHEDULE 13D




Comment for Type of Reporting Person:
Calculated based on 129,600,040 shares of Class A Shares outstanding as of May 5, 2026, as reported on the Issuer's Form 10-Q.


SCHEDULE 13D




Comment for Type of Reporting Person:
Calculated based on 129,600,040 shares of Class A Shares outstanding as of May 5, 2026, as reported on the Issuer's Form 10-Q.


SCHEDULE 13D




Comment for Type of Reporting Person:
Calculated based on 129,600,040 shares of Class A Shares outstanding as of May 5, 2026, as reported on the Issuer's Form 10-Q.


SCHEDULE 13D




Comment for Type of Reporting Person:
Calculated based on 129,600,040 shares of Class A Shares outstanding as of May 5, 2026, as reported on the Issuer's Form 10-Q.


SCHEDULE 13D




Comment for Type of Reporting Person:
Calculated based on 129,600,040 shares of Class A Shares outstanding as of May 5, 2026, as reported on the Issuer's Form 10-Q.


SCHEDULE 13D


LCP Edge Holdco, LLC
Signature:/s/ Brian Miller
Name/Title:Brian Miller / President
Date:05/11/2026
Linden Capital III LLC
Signature:/s/ Brian Miller
Name/Title:Brian Miller / Managing Partner
Date:05/11/2026
Linden Manager III LP
Signature:/s/ Brian Miller
Name/Title:Brian Miller / Managing Partner
Date:05/11/2026
Linden Capital Partners III LP
Signature:/s/ Brian Miller
Name/Title:Brian Miller / Managing Partner
Date:05/11/2026
Linden Capital Partners III-A LP
Signature:/s/ Brian Miller
Name/Title:Brian Miller / Managing Partner
Date:05/11/2026
Anthony Davis
Signature:/s/ Brian Miller
Name/Title:Brian Miller / Attorney-in-Fact
Date:05/11/2026
Brian Miller
Signature:/s/ Brian Miller
Name/Title:Brian Miller
Date:05/11/2026
Comments accompanying signature:
Linden Manager III LP, By: Linden Capital III LLC Its: General Partner. Linden Capital Partners III LP, By: Linden Manager III LP Its: General Partner, By: Linden Capital III LLC Its: General Partner. Linden Capital Partners III-A LP, By: Linden Manager III LP Its: General Partner, By: Linden Capital III LLC Its: General Partner.

Categories

SEC Filings